GLPwatch

Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend.

J Endocr Soc · 2025

Last updated 2026-05-28

Compounded weight-loss drugs are becoming more common worldwide, driven by demand for quick results, weak regulations, and easy online access. These products pose risks, especially to people seeking cheaper options. Experts recommend stronger oversight, public education, and teamwork among regulators to address the issue and protect consumers.

AI summary of the abstract below.

JournalJ Endocr Soc, 2025
Citations3
Molecules
Conditions studied Obesity

Abstract

The rise of compounded weight-loss drugs has emerged as a pressing global health issue, threatening consumers and health-care systems. Factors fueling this crisis include the desire for rapid weight-loss options, inadequate regulatory frameworks, and the easy availability of compounded products through online platforms and social media. Vulnerable populations, particularly those searching for low-cost treatments, are hit hardest. Tackling this escalating problem calls for a comprehensive strategy: enhancing regulatory oversight, raising public awareness, and fostering stakeholder collaboration. We can reduce the health dangers of compounded weight-loss medications by addressing the underlying causes and improving consumer safety. This article examines the risks associated with compounded weight-loss drugs and suggests practical measures to protect public health.

Verbatim abstract via PubMed 40520450 ↗